Peer Review History

Original SubmissionJune 2, 2020
Decision Letter - Chaowei Yang, Editor

PONE-D-20-16721

The Impacts of COVID-19 Pandemic on Public Transit Demand in the United States: An Analysis Using Smartphone Data

PLOS ONE

Dear Dr. Liu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please properly address the two reviewers' comments are attached. In addition, please also note the innovative aspects of the research and the spatiotemporal dimension in the revised version. 

Please submit your revised manuscript by July 15, 2020. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Chaowei Yang

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In ethics statement in the manuscript and in the online submission form, please confirm that only publicly available data have been used in your study, and that no users' personal information have been accessed or collected.

3. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

4.  Thank you for stating the following in the Financial Disclosure section:

"The author(s) received no specific funding for this work."

We note that one or more of the authors are employed by a commercial company: "Transit App Inc.,"

a) Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form.

Please also include the following statement within your amended Funding Statement.

“The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.”

If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement.

b)  Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc. 

Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests) . If this adherence statement is not accurate and  there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

5. Please amend either the title on the online submission form (via Edit Submission) or the title in the manuscript so that they are identical.

6. Please remove your figures from within your manuscript file, leaving only the individual TIFF/EPS image files, uploaded separately.  These will be automatically included in the reviewers’ PDF.

7. Please ensure that you refer to Figure 4 in your text as, if accepted, production will need this reference to link the reader to the figure

8. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 1 in your text; if accepted, production will need this reference to link the reader to the Table.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This paper studied an interesting and timely research question regarding the transit demand change during the COVID-19 pandemic. The authors employed the data from Transit App to capture transit demand and derived various indexes to describe the change patterns. Overall, this study offers timely data analytics to monitor transit demand during COVID-19. However, there are still several notable concerns with this paper. Detailed comments follow:

The methodological contribution of this paper is limited. Most analyses conducted in this study are descriptive, and the whole paper lacks convincing and strict model build and description:

1) The authors employed a logistic function to fit the transit demand data for each transit system. First, the logistic function is quite different from the logistic model, the authors should be careful when describing their methods. Second, I failed to found any results of the logistic functions. The authors should at least give a summary of the fitting accuracy and statistical significance of the logistic functions for different transit systems.

2) When modeling the factors related to floor value, some essential variables are missing. For example, the population density, the job density, and the factors related to transit accessibility (for example, the number of transit stations in each city. The data can be derived from OSM POI). The authors should do more literature review regarding the built environment and public transit to understand which covariates are essential.

3) Is the simple linear model appropriate to fit the floor value? Do the data meet the normality assumption? How to handle spatial auto-correlations? The authors should address these issues before using an OLS model.

4) Why the authors only build a model for floor value, while ignoring the other indexes like cliff and floor points, response intervals, the decay rate?

The visualization part is insufficient also. At least two figures are important but missing. First, a figure of the transit demand varying patterns across the study period. Second, a figure visualizing the observed data versus the fitted data using the logistic function. The indexes like floor value, cliff and floor points, response intervals, the decay rate, can also be annotated in the figures.

Some other minor comments:

1) The authors should involve a proofreader to improve writing. Many words are unprofessional and hard to understand. For example, the floor value mostly means the closest integer less than or equal to a given number, rather than the lowest plateau value the authors want to express.

2) The holidays should be excluded from the study periods due to the unusual human mobility patterns.

3) The authors should also report the variables with insignificant P-values in Table 1.

4) In Line 353, why does the ratio of female have high multi-collinearity with the ratio of African Americans?

Reviewer #2: This interesting paper investigates the impacts of the COVID-19 pandemic of public transit ridership across major systems in the US. The main data supporting this research are provided by the Transit app. It is a very timely effort, focusing on an important topic with a strong tie to the society. Methods are adequate. But I have several concerns for the authors to address.

1. Introduction section is not very motivating. For example, why is it important to study the changes in public transit ridership, along with some metrics like the floor value and so on? What knowledge do we gain from this? How can this knowledge be beneficial to the society? The authors could’ve done a better job discussing these points.

2. My major concern is that there is no lit review in this paper. Without discussing previous studies of relevant scopes, how can we know the research gap and the contributions of this work? It is important to add such a section to back up your ideas.

3. Variables. The authors should justify why some variables are selected. I am concerned about a few varaibles. One such variable, for example, is the occupation type factor. As described in lines 168-169, “Information, Financial activities, and professional and business service” were selected and adopted in the model. The assumption, as detailed in lines 164-165 and line 169, is that these types of workers are more likely to work from home during this pandemic and thus areas with more of these workers are more likely to experience a greater hit in ridership. This assumption/assertion is somehow problematic. I think these subgroups are less likely to use public transit but instead rely more on private vehicles before this pandemic. That said, they may not be an important component to the typical ridership. Therefore, looking at communities with higher percentage of these workers for examining sudden ridership change is less convincing.

In addition to the variables already included in the model, I think the number of homeless people should be considered. Homeless people are more likely to take/occupy public transit, especially in large cities like NYC. As this particular subgroup of population reportedly has higher infection risk, the related transit systems may be affected more severely. This can also be related to the awareness factor discussed in the paper.

4. Provide more details. Throughout the paper, the authors claimed that the Transit app is a widely used app. The only statements related to this is in lines 99-101—“the app covers over 200 cities aournd the world with … download on…” This is insufficient to back up the point that it is a widely used app, and thus leading me to question the representativeness of the data. As the study area is the US, so the authors should provide more details about the user coverage and usage stats (ideally some comparisons with other competitors for showing its market share) to define how “widely” it is being used in the US.

More details about methods/analyses. Section 2 describes the analyses/methods, but I find it a bit loosely connected. More details should be provided to better connect these steps and help readers get the full picture.

I think it would be great if every city in the maps is labeled.

5. Figure 1. Why COVID curve (orange) is more prominent than the typical curve (blue)?

6. There are many typos and formatting issues in the paper, making it difficult to read. The language should be improved.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Chenfeng Xiong

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Please find our responses to the reviewers in the attached files.

Attachments
Attachment
Submitted filename: response_to_reviewers.docx
Decision Letter - Chaowei Yang, Editor

The impacts of COVID-19 pandemic on public transit demand in the United States

PONE-D-20-16721R1

Dear Dr. Liu,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Chaowei Yang

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: (No Response)

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: (No Response)

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: (No Response)

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: (No Response)

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: I am happy with the revision. One minor suggestion though. To map all the cities with labels in one map, I guess the authors could make several inset maps zooming into particular regions such as Los Angeles so that labels do not clutter.

Reviewer #3: This manuscript represented a timely effort that show public transit demand change in the U.S. during the pandemic with Transit app dataset by adopting logistic statistical analysis. All comments from first round reviewing have been addressed propriety. This revised manuscript has met the standard for further proceeding.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: Yes: Yujie Hu

Reviewer #3: No

Formally Accepted
Acceptance Letter - Chaowei Yang, Editor

PONE-D-20-16721R1

The impacts of COVID-19 pandemic on public transit demand in the United States

Dear Dr. Liu:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Chaowei Yang

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .